Advances in the Pharmacological Treatment of Pathological Gambling

被引：41
作者：
Jon E. Grant
Suck Won Kim
Marc N. Potenza
机构：
[1] University of Minnesota School of Medicine,Department of Psychiatry
[2] University of Minnesota,undefined
[3] Yale University,undefined
来源：
Journal of Gambling Studies | 2003年 / 19卷 / 1期
关键词：
pathological gambling; impulse control; psychopharmacology;
D O I：
10.1023/A:1021227214142
中图分类号：
学科分类号：
摘要：
In the present paper we discuss the current status of drug treatment for pathological gambling and the scientific rationales underlying the various pharmacological approaches. Specifically, we summarize the treatment study results of serotonin reuptake inhibitors, mood stabilizers, opioid antagonists, and atypical antipsychotics in pathological gambling. We also discuss dosage strategies, the duration of treatment, issues surrounding medication compliance, and approaches to treatment-refractory pathological gambling, such as pharmacological and behavioral augmentation.
引用
收藏
页码：85 / 109
页数：24
相关论文
共 328 条
[1]  
Albanese M.J.(1994)Decreased substance use in chronically psychotic patients treated with clozapine American Journal of Psychiatry 151 780-781
[2]  
Khantzian E.J.(1989)Effects of naloxone and naltrexone on self-injury: a double-blind, placebo-controlled analysis American Journal of Mental Retardation 93 644-651
[3]  
Murphy S.L.(2001)Pathological gambling: addiction or compulsion? Seminars in Clinical Neuropsychiatry 6 167-176
[4]  
Green A.I.(1996)Pathological gambling and platelet MAO activity: a psychobiological study American Journal of Psychiatry 153 119-121
[5]  
Barrett R.P.(2002)A pilot placebo-controlled study of fluvoxamine for pathological gambling Annals of Clinical Psychiatry 14 9-15
[6]  
Feinstein C.(1979)Facilitation of self-stimulation behavior following intracerebral microinjections of opioids into the ventral tegmental area Pharmacology Biochemistry and Behavior 11 289-295
[7]  
Hole W.T.(1994)Substance abuse among patients with treatment-resistant schizophrenia: characteristics and implications for clozapine therapy American Journal of Psychiatry 151 385-389
[8]  
Blanco C.(1994)Low platelet monoamine oxidase activity in pathological gambling Acta Psychiatrica Scandinavia 90 427-31
[9]  
Moreyra P.(2001)Targeting behavioral therapies to enhance naltrexone treatment of opioid dependence Archives of General Psychiatry 58 755-761
[10]  
Nunes E.V.(2001)A neurobiological basis for substance abuse comorbidity in schizophrenia Biological Psychiatry 50 71-83
12345678910